Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sandoz' Clozaril

Executive Summary

More than 40 state Medicaid agencies now cover the antischizophrenic agent (clozapine), the firm announced April 23. "Many" states decided to provide reimbursement for Clozaril therapy since April 1, when Sandoz announced availability of the drug through normal wholesale channels ("The Pink Sheet" April 1, T&G-2 and April 15, T&G-6) .... Norplant Foundation: Wyeth- Ayerst is providing $ 2.8 mil. to establish a foundation assisting women who could not otherwise afford the implanted contraceptive. Program will be directed by Philip Darney, MD, San Francisco General Hospital Family Planning Clinic director. The five-year Norplant System costs about $ 350, including certain equipment needed to implant the product ("The Pink Sheet" Feb. 11, In Brief). Wyeth Ayerst said 23 state Medicaid agencies now cover Norplant.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS019125

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel